Flora Growth Corp.
FLGCNASDAQHealthcare
$7.79
$-3.69(-32.14%)
Market Cap$4226379
P/E Ratio—
52W High$47
52W Low$5.86
Flora Growth Corp. (FLGC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
FLGC · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 5, 2025EPS Actual
-$4.93
Est. -$2.13 · -131.5%
Revenue
$0.01B
Est. $0.01B · -22.0%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 5, 2025
After Market Close
▼ Miss EPS▼ Miss Revenue
FLGC reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Feb 27, 2026 | -$1.18 | — | — | $-0.02B | $0.01B | -266.6% |
| ▼ Q4 FY2025 | Nov 5, 2025 | -$2.13 | -$4.93 | -131.5% | $0.01B | $0.01B | -22.0% |
| ▼ Q3 FY2025 | Aug 1, 2025 | -$2.34 | -$4.30 | -83.8% | $0.01B | $0.01B | +25.4% |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.39 | -$1.56 | -300.0% | $0.01B | $0.02B | -27.7% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -$0.11 | -$16.41 | -14818.2% | $0.01B | $0.01B | -1.3% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$3.52 | -$9.38 | -166.5% | $0.01B | $0.02B | -25.7% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -$1.95 | -$8.59 | -340.5% | $0.02B | $0.02B | -24.4% |
| ▼ Q2 FY2024 | May 14, 2024 | -$8.59 | -$10.94 | -27.4% | $0.02B | $0.02B | -5.3% |
Q1 FY2026
Feb 27, 2026
EPS Actual
—
EPS Est.
-$1.18
EPS Surpr.
—
Revenue
$-0.02B
Q4 FY2025
Nov 5, 2025Miss
EPS Actual
-$4.93
EPS Est.
-$2.13
EPS Surpr.
-131.5%
Revenue
$0.01B
Q3 FY2025
Aug 1, 2025Miss
EPS Actual
-$4.30
EPS Est.
-$2.34
EPS Surpr.
-83.8%
Revenue
$0.01B
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$1.56
EPS Est.
-$0.39
EPS Surpr.
-300.0%
Revenue
$0.01B
Q1 FY2025
Mar 24, 2025Miss
EPS Actual
-$16.41
EPS Est.
-$0.11
EPS Surpr.
-14818.2%
Revenue
$0.01B
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$9.38
EPS Est.
-$3.52
EPS Surpr.
-166.5%
Revenue
$0.01B
Q3 FY2024
Aug 12, 2024Miss
EPS Actual
-$8.59
EPS Est.
-$1.95
EPS Surpr.
-340.5%
Revenue
$0.02B
Q2 FY2024
May 14, 2024Miss
EPS Actual
-$10.94
EPS Est.
-$8.59
EPS Surpr.
-27.4%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.32 | $0.32 | $0.32 | 1 |
| Q3 FY2026 | $0.17 | $0.17 | $0.17 | 1 |
| Q2 FY2026 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Q1 FY2026 | $-1.18 | $-1.18 | $-1.18 | 1 |
| Q4 FY2025 | $-0.39 | $-0.39 | $-0.39 | 1 |
| Q3 FY2025 | $-2.13 | $-2.13 | $-2.13 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2025 | Nov 5, 2025 | -131.5% | $9.38 | $9.50 | +1.28% |
| ▼ Q3 FY2025 | Aug 1, 2025 | -83.8% | $22.95 | $19.89 | -13.33% |
| ▼ Q2 FY2025 | May 13, 2025 | -300.0% | $29.25 | $28.38 | -2.97% |
| ▼ Q1 FY2025 | Mar 24, 2025 | -14818.2% | $24.18 | $25.62 | +5.96% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -166.5% | $46.02 | $44.07 | -4.24% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -340.5% | $36.65 | $36.27 | -1.04% |
| ▼ Q2 FY2024 | May 14, 2024 | -27.4% | $52.65 | $49.92 | -5.19% |
| ▼ Q1 FY2024 | Mar 29, 2024 | -142.9% | $90.09 | $88.92 | -1.30% |
Q4 FY2025+1.28%
Report Date
Nov 5, 2025
EPS Beat/Miss
-131.5%
Price Before
$9.38
Price After
$9.50
Q3 FY2025-13.33%
Report Date
Aug 1, 2025
EPS Beat/Miss
-83.8%
Price Before
$22.95
Price After
$19.89
Q2 FY2025-2.97%
Report Date
May 13, 2025
EPS Beat/Miss
-300.0%
Price Before
$29.25
Price After
$28.38
Q1 FY2025+5.96%
Report Date
Mar 24, 2025
EPS Beat/Miss
-14818.2%
Price Before
$24.18
Price After
$25.62
Q4 FY2024-4.24%
Report Date
Nov 13, 2024
EPS Beat/Miss
-166.5%
Price Before
$46.02
Price After
$44.07
Q3 FY2024-1.04%
Report Date
Aug 12, 2024
EPS Beat/Miss
-340.5%
Price Before
$36.65
Price After
$36.27
Q2 FY2024-5.19%
Report Date
May 14, 2024
EPS Beat/Miss
-27.4%
Price Before
$52.65
Price After
$49.92
Q1 FY2024-1.30%
Report Date
Mar 29, 2024
EPS Beat/Miss
-142.9%
Price Before
$90.09
Price After
$88.92
Avg Miss Reaction-2.60%
Beat Rate0 / 8 quarters
Largest Move-13.33% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: FLGC ends December
Flora Growth Corp. (FLGC) most recently reported earnings on November 5, 2025 for Q4 FY2025, posting EPS of $-4.93 — missing the analyst consensus of $-2.13 by -131.5%. The next FLGC earnings date is expected around September 1, 2026.
Each quarter, investors track FLGC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. FLGC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
FLGC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
FLGC earnings · 5 questionsFlora Growth Corp.'s next earnings report is expected around September 1, 2026. FLGC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; FLGC historically reports after market close (AMC).
FLGC earnings datewhen is FLGC earningsFLGC next earnings datewhen does FLGC report earningsFLGC earnings calendar
▸ Source: FMP · Flora Growth Corp. SEC filings · US GAAP · Flora Growth Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026